Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8502018 Methods of modifying eukaryotic cells

Patent 8502018 was granted and assigned to Regeneron Pharmaceuticals, Inc. on August, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

85020180

Date of Patent

August 6, 2013

Patent Application Number

131641760

Date Filed

June 20, 2011

Patent Citations Received

‌

US Patent 12065661 Genetic modification of rats

‌

US Patent 12004495 Genetically modified non-human animals with humanized immunoglobulin locus

‌

US Patent 12016313 Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci

‌

US Patent 12060571 Methods and compositions for modifying a targeted locus

‌

US Patent 11707056 Animals, repertoires and methods

‌

US Patent 11785924 Antibody producing non-human animals

‌

US Patent 11858993 Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof

‌

US Patent 11877565 Antibody production

...

Patent Primary Examiner

‌

Gerald Leffers, Jr.

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8502018 Methods of modifying eukaryotic cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API